Dr. Anas is currently the Director of the Pharmacy Department at Qatar's National Center for Cancer Care and Research. He is the Head of Medication Safety C Quality Center and Head of Pharmacy Research Center at Hamad Medical Corporation's Pharmacy Executive Office. He holds a position at Qatar University as a Clinical Associate Professor of Clinical Pharmacy C Practice. He chairs the Standing Committee on Medication Services at the Qatar Red Crescent Society. He is also the Vice President and Director of the ISPOR Qatar Chapter. Additionally, he is leading the Health Technology Assessment and Innovation Regulation Project under the National Health Strategy at the Ministry of Public Health.
Dr. Anas finished his BSc in Pharmacy at the University of Jordan. He obtained an MSc in Clinical Pharmacy and International Practice C Policy from the University of London, and a PhD in Clinical Practice and Medication Use from King's College London. He also acquired an Executive Diploma in Health Services Management from GSM London. Furthermore, he completed the Executive Leaders Program with Qatar Leadership Centre. That is in addition to multiple postgraduate certificates in health technology assessment, supply chain management, human subjects research, quality management, health economics, and outcomes research.
Dr. Anas is an active researcher with several publications and conference proceedings. He is an Editorial Board Member at the International Journal of Clinical Pharmacy and Review Editor at Frontiers in Oncology. He regularly speaks at local and international conferences. He is a member of both HMC's and QU's Institutional Review Boards in addition to the MOPH National Clinical Research Review Committee. Moreover, he is a member of various committees/boards focusing on pharmacy practice, medication use, cancer care, research, safety C quality, medical affairs, healthcare education, health economics, governmental tenders, clinical transformation, and health insurance.
